Serina Therapeutics, Inc. (SER): debt financing — AgeX draws $500K under existing secured note with Juvenescence, due Feb 14, 2024

Serina Therapeutics, Inc.

$500,000 drawn on Jan 16, 2024 from Amended & Restated Secured Convertible Note with Juvenescence Ltd.
Repayment date set for February 14, 2024 (approximately one month).
Full terms of Secured Note previously disclosed in Nov 14, 2023 10-Q filing.

item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Serina Therapeutics, Inc. incurred convertible notes of $500,000 with Juvenescence Limited maturing February 14, 2024.

Instrument: convertible notes
Principal: $500,000
Counterparty: Juvenescence Limited
Maturity: February 14, 2024
Event: incurrence

Exact text from the filing

On January 16, 2024, AgeX drew $500,000 of its credit available under the Amended and Restated Secured Convertible Promissory Note, as amended, (“Secured Note”) with Juvenescence Limited (“Juvenescence”).

View on SEC.gov

283 debt financings filed in the last 30 days. Browse all debt financings →

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-003057

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.